Rheumatologists choose, review top mobile health devices
Tom Collins is a freelance writer in South Florida, who has written about medical topics from nasty infections to ethical dilemmas, runaway tumors to tornado-chasing doctors. He travels the globe gathering conference health news and lives in West Palm Beach.
Articles by Thomas R. Collins
Tech Talk: Physicians Debate Using Cell Phones to Communicate with Patients
Concerns about protecting personal privacy and receiving after-hours calls are balanced by physicians’ desire to connect with patients
EULAR 2013: New RA Recommendations Address Combination Therapy Concerns
Guidelines give greater nod to use of combination conventional disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis, leave monotherapy with methotrexate as acceptable first-line treatment
Tech Talk: New Technologies Attempt to Find Better Treatments for Rheumatic Diseases
Research in proteomics and genetics sheds new light on treatment strategies, brings potential for breakthroughs
EULAR 2013: Researchers Expand Targets for PsA, OA Therapy
Experts discuss insights in the pathogenesis of psoriatic arthritis and the role of subchondral bone in osteoarthritis
EULAR 2013: Drugs New and Old Could Treat Spondylarthropies
Nonsteroidal anti-inflammatory drugs (NSAIDs) might still have a role in treating axial spondylarthritis, but other drugs, therapies are being explored
EULAR 2013: Researchers Make Inroads in Treatment of Osteoarthritis
Experts discuss evidence-based benefits of knee joint distraction and the progress being made in harnessing the effects of stem cells
EULAR 2013: Tips for Managing Peripheral Neuropathy in Rheumatic Disease
How to determine which tests to order, how to interpret them, and how to decide on the right treatment course
EULAR 2013: Emerging Imaging Methods in Spondylarthritis Have Advantages and Flaws
New technologies from diffusion-weighted imaging to ultrasonography are being studied and refined, but much is yet to be understood
EULAR 2013: Research Hints at Risk Factors for Rheumatoid Arthritis
Studies point to involvement of anti-CCP antibodies and citrullinated targets in the lungs and joints in the development of RA, and suggest an early therapeutic window for prevention
- « Previous Page
- 1
- …
- 26
- 27
- 28
- 29
- 30
- …
- 32
- Next Page »